Drug recall · March 6, 2024
Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1 recall
Why: Subpotent Drug: Out of specification for assay
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Omeprazole and Sodium Bicarbonate For Oral Suspension 40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.
- Lots / codes
Lot #0013R; Exp. 01/2026
- Quantity
- 3,600 cartons
- Company
- Bausch Health Companies, Inc., Bridgewater, NJ
- Distribution
- Nationwide
- Initiated
- February 2, 2024 · Voluntary: Firm initiated
- Classified
- February 28, 2024
- Reported
- March 6, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Omeprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.